Similar articles

• [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy].

  Portegies P, Goudsmit J. Portegies P, et al. Ned Tijdschr Geneeskd. 1991 Jul 20;135(29):1302-6. Ned Tijdschr Geneeskd. 1991. PMID: 1865933 Review. Dutch. No abstract available.
• T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1.

  Lee JW, Fox EP, Rodgers-Johnson P, Gibbs CJ Jr, DeFreitas E, Manns A, Blattner W, Cotelingam J, Piccardo P, Mora C, et al. Lee JW, et al. Ann Intern Med. 1989 Feb 1;110(3):239-41. doi: 10.7326/0003-4819-110-3-239. Ann Intern Med. 1989. PMID: 2536259 No abstract available.
• Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.

  Sarin PS, Rodgers-Johnson P, Sun DK, Thornton AH, Morgan OS, Gibbs WN, Mora C, McKhann G 2nd, Gajdusek DC, Gibbs CJ Jr. Sarin PS, et al. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2021-5. doi: 10.1073/pnas.86.6.2021. Proc Natl Acad Sci U S A. 1989. PMID: 2467295 Free PMC article.
• Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.

  Matsuo T, Miyata Y, Nakamura T, Satoh K, Sakai H. Matsuo T, et al. Int J Urol. 2018 Jan;25(1):54-60. doi: 10.1111/iju.13468. Epub 2017 Oct 1. Int J Urol. 2018. PMID: 28965354 Clinical Trial.
• [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].

  Yamano Y, Sato T. Yamano Y, et al. Nihon Rinsho. 2013 May;71(5):870-5. Nihon Rinsho. 2013. PMID: 23777097 Review. Japanese.